Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mangoceuticals, Inc. ( (MGRX) ) has provided an announcement.
On May 23, 2025, Mangoceuticals, Inc. entered into Subscription Agreements with two accredited investors, resulting in the issuance of 70,454 shares of common stock and warrants to purchase 35,227 shares, raising $116,249. The Investor Warrants have specific exercise conditions and beneficial ownership limitations. Additionally, on May 27, 2025, the company amended a previous promissory note with Indigo Capital LP, allowing conversion into common stock and removing mandatory prepayment requirements. Furthermore, Mangoceuticals entered a digital marketing agreement with Levo Healthcare Consulting, Inc., issuing 120,000 shares of restricted common stock in exchange for services starting June 1, 2025. These strategic financial moves aim to enhance the company’s capital structure and marketing capabilities.
More about Mangoceuticals, Inc.
Average Trading Volume: 283,338
Technical Sentiment Signal: Sell
Current Market Cap: $26.7M
See more data about MGRX stock on TipRanks’ Stock Analysis page.